For decades, tubo-ovarian cancer has been the most lethal gynaecological malignancy, with negligible improvement in the 5-year survival rates over the past decades despite advancements in treatment.
Jurgen M Piek (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: